Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 22 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 9636515

    Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use

    Advanced Neuroregenerative Therapies, LLC. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted

  2. US 9629897

    Methods of producing and using regulatory B-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  3. US 9629877

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  4. US 9624472

    Production of insulin producing cells

    Regents of the University of Minnesota · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  5. US 9623040

    Immunomodulation by controlling expression levels of microRNAs in dendritic cells

    The Regents of the University of California · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  6. US 9624509

    Modulation of stem cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  7. US 9617512

    Derivation of embryonic stem cells and embryo-derived cells

    Astellas Institute for Regenerative Medicine · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  8. US 9616090

    Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

    Sangamo Biosciences, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  9. US 9611456

    Progenitor cells from wharton'S jelly of human umbilical cord

    Tissue Regeneration Therapeutics Inc. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  10. US 9592304

    Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  11. US 9593162

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  12. US 9566352

    Methods and compositions for inhibiting viral entry into cells

    Sangamo Biosciences, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  13. US 9566250

    Artificial tissue constructs comprising alveolar cells and methods for using the same

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  14. US 9567402

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  15. US 9567564

    Progenitor cells from Wharton's jelly of human umbilical cord

    Tissue Regeneration Therapeutics Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  16. US 9562237

    Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  17. US 9549954

    Method and composition for inducing human pluripotent stem cells

    The Regents of the University of California · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  18. US 9550974

    Derivation of embryonic stem cells

    Astellas Institute for Regenerative Medicine · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  19. US 9545422

    Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells

    The Regents of the University of California · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  20. US 9545451

    Anti-PRLR antibodies and methods for killing PRLR-expressing cells

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  21. US 9539341

    Methods and compositions for targeting adipose cells in mammals

    The Board of Regents of the University of Texas System · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  22. US 9526747

    Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure

    Regents of the University of Minnesota · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  23. US 9506041

    Delivery of packaged RNA to mammalian cells

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

  24. US 9498544

    Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

    Tissue Regeneration Therapeutics Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.